Shih H Chu

Title: Innovations by Inventor Shih H Chu

Introduction

Shih H Chu is a notable inventor based in Barrington, RI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral and anti-cancer agents. With a total of 2 patents, his work has the potential to impact the treatment of serious health conditions.

Latest Patents

One of Shih H Chu's latest patents involves the creation of novel 6-pyridyl substituted pyrimidine derivatives. These compounds are designed for use as antiviral agents, specifically targeting retroviral infections such as HIV and related disorders. Additionally, they are intended for use in anti-cancer therapies to enhance the effectiveness of existing treatments. The compounds work by disrupting viral replication while exhibiting lower cell toxicity, making them more efficient for prolonged antiviral therapy. Furthermore, these derivatives can improve the efficacy of anti-cancer therapeutics, such as 5-fluorouracil, thereby reducing the required dosage and minimizing toxic effects on the host.

Another patent focuses on hydroxymethyl derivatives of 5-benzylacyclouridine. This compound is characterized by a specific formula where X can be a benzyl group or a benzyloxybenzyl group. The patent also includes pharmaceutical preparations containing these derivatives, showcasing Shih H Chu's innovative approach to drug development.

Career Highlights

Shih H Chu is affiliated with Brown University, where he continues to engage in research and development in the pharmaceutical field. His work is characterized by a commitment to improving therapeutic options for patients suffering from viral infections and cancer.

Collaborations

Throughout his career, Shih H Chu has collaborated with esteemed colleagues, including Paul Calabresi and Ming Y Chu. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

In summary, Shih H Chu is an accomplished inventor whose work in developing antiviral and anti-cancer agents holds promise for improving patient outcomes. His innovative patents reflect a dedication to addressing critical health challenges through scientific research and collaboration.